$4.68
0.112.41%
At close: -
$4.45
-0.23-4.91%
After Hours: 7:58 PM EDT
Comments
Loading...
Aligos Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:ALGS | Benzinga
Aligos Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 6
EPS Estimate
$-2.970
Quarterly Revenue Estimate
$333.33K
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$3.94M
Analyze the earnings history of Aligos Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ALGS | Aligos Therapeutics | -$5.50 | -$2.97 | — | — | $986.00K | $333.33K | — | — | 05/06/2025 | Get Alert |
| ALGS | Aligos Therapeutics | -$5.50 | -$3.67 | -$13.08 | -256.40% | $2.01M | $433.33K | $629.00K | 45.15% | 03/10/2025 | Get Alert |
| ALGS | Aligos Therapeutics | -$10.25 | -$2.16 | -$3.07 | -42.13% | $2.15M | $330.00K | $1.27M | 284.55% | 11/06/2024 | Get Alert |
| ALGS | Aligos Therapeutics | -$10.75 | -$4.00 | $0.75 | 118.75% | $2.59M | — | $1.06M | — | 08/06/2024 | Get Alert |
| ALGS | Aligos Therapeutics | -$13.25 | -$4.75 | -$5.50 | -15.79% | $2.72M | — | $986.00K | — | 05/07/2024 | Get Alert |
| ALGS | Aligos Therapeutics | -$12.75 | -$6.75 | -$5.50 | 18.52% | $3.54M | $1.60M | $2.01M | 25.56% | 03/12/2024 | Get Alert |
| ALGS | Aligos Therapeutics | -$11.00 | -$11.75 | -$10.25 | 12.77% | $4.11M | $2.50M | $2.15M | -13.84% | 11/02/2023 | Get Alert |
| ALGS | Aligos Therapeutics | -$11.75 | -$12.25 | -$10.75 | 12.24% | $3.69M | — | $2.59M | — | 08/03/2023 | Get Alert |
| ALGS | Aligos Therapeutics | -$21.00 | -$12.00 | -$13.25 | -10.42% | $2.57M | — | $2.72M | — | 05/04/2023 | Get Alert |
| ALGS | Aligos Therapeutics | -$22.25 | -$11.75 | -$12.75 | -8.51% | $367.00K | $1.72M | $3.54M | 105.64% | 03/09/2023 | Get Alert |
| ALGS | Aligos Therapeutics | -$19.50 | -$14.50 | -$11.00 | 24.14% | $1.54M | — | $4.11M | — | 11/02/2022 | Get Alert |
| ALGS | Aligos Therapeutics | -$19.75 | -$16.75 | -$11.75 | 29.85% | $1.54M | — | $3.69M | — | 08/04/2022 | Get Alert |
| ALGS | Aligos Therapeutics | -$18.50 | -$18.25 | -$21.00 | -15.07% | $910.00K | — | $2.57M | — | 05/04/2022 | Get Alert |
| ALGS | Aligos Therapeutics | -$27.25 | -$20.75 | -$22.25 | -7.23% | $0.00 | — | $367.00K | — | 03/10/2022 | Get Alert |
| ALGS | Aligos Therapeutics | -$275.00 | -$20.25 | -$19.50 | 3.70% | $0.00 | — | $1.54M | — | 11/04/2021 | Get Alert |
| ALGS | Aligos Therapeutics | — | -$20.25 | -$19.75 | 2.47% | — | — | $1.54M | — | 08/05/2021 | Get Alert |
| ALGS | Aligos Therapeutics | — | -$22.50 | -$18.50 | 17.78% | — | — | $910.00K | — | 05/10/2021 | Get Alert |
| ALGS | Aligos Therapeutics | -$181.75 | — | -$27.25 | — | — | — | $0.00 | — | 03/23/2021 | Get Alert |
| ALGS | Aligos Therapeutics | — | — | -$275.00 | — | — | — | $0.00 | — | 11/25/2020 | Get Alert |
Aligos Therapeutics (ALGS) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-10 | $-13.08 | $-3.67 | -256.4 % |
| Q3 | 2024-11-06 | $-3.07 | $-2.16 | -42.1 % |
| Q2 | 2024-08-06 | $0.75 | $-4.00 | 118.8 % |
| Q1 | 2024-05-07 | $-5.50 | $-4.75 | -15.8 % |
Aligos Therapeutics (ALGS) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-10 | $629.00K | $433.33K | 45.1 % |
| Q3 | 2024-11-06 | $1.27M | $330.00K | 284.6 % |
| Q4 | 2024-03-12 | $2.01M | $1.60M | 25.6 % |
| Q3 | 2023-11-02 | $2.15M | $2.50M | -13.8 % |
FAQ
When is Aligos Therapeutics (NASDAQ:ALGS) reporting earnings?
Aligos Therapeutics (ALGS) is scheduled to report earnings on May 6, 2025. The last reported earnings were for reported on March 10, 2025 for Q4.
What were the latest earnings per share (EPS) for Aligos Therapeutics (NASDAQ:ALGS)?
The Actual EPS was $-13.08, which missed the estimate of $-3.67.
What were Aligos Therapeutics’s (NASDAQ:ALGS) revenues?
The Actual Revenue was $629K, which beat the estimate of $433.3K.
Browse earnings estimates, EPS, and revenue on all stocks.
